Shenxin Lu

机构：Jiangnan University, Sun Yat-sen University, Fudan University, National Clinical Research Center for Digestive Diseases, Zhongshan Hospital, The First Affiliated Hospital, Sun Yat-sen University · ORCID：0000-0003-2744-5635

发表论文 30 篇 · 总被引 221 次 · h-index 8

代表论文

Oxaliplatin-Resistant Hepatocellular Carcinoma Drives Immune Evasion Through PD-L1 Up-Regulation and PMN-Singular Recruitment (2022 · Cellular and Molecular Gastroenterology and Hepatology · 被引 33)
Albumin-to-alkaline phosphatase ratio as a predictor of tumor recurrence and prognosis in patients with early-stage hepatocellular carcinoma undergoing radiofrequency ablation as initial therapy (2021 · International Journal of Hyperthermia · 被引 27)
Albumin-bilirubin index and platelet-albumin-bilirubin index contribute to identifying survival benefit candidates in patients with hepatocellular carcinoma and Child-Pugh grade A undergoing transcatheter arterial chemoembolization with sorafenib treatment (2021 · Annals of Translational Medicine · 被引 21)
The prognostic significance of microRNA-221 in hepatocellular carcinoma: An updated meta-analysis (2021 · The International Journal of Biological Markers · 被引 10)
Prognostic significance of preoperative systemic immune-inflammation index in combined hepatocellular-cholangiocarcinoma (2021 · Cancer Biomarkers · 被引 10)
Gas7 attenuates hepatocellular carcinoma progression and chemoresistance through the PI3K/Akt signaling pathway (2023 · Cellular Signalling · 被引 8)